Table 1 The clinical information of the obtained patients treated with osimertinib for about 9Â months
No | Sex | Age | Disease | Distant metastases | Smoke | Resistance to osimertinib |
|---|---|---|---|---|---|---|
1 | Male | 56 | Left upper-lobe adenocarcinoma | Yes | Yes | Resistant |
2 | Female | 61 | Right lower-lobe adenocarcinoma | Yes | No | Resistant |
3 | Female | 53 | Right middle-lobe adenocarcinoma | Yes | No | Resistant |
4 | Female | 64 | Left upper-lobe adenocarcinoma | Yes | No | Resistant |
5 | Male | 72 | Left lower-lobe adenocarcinoma | Yes | Yes | Sensitive |
6 | Female | 65 | Left upper-lobe adenocarcinoma | Yes | No | Sensitive |
7 | Male | 57 | Left upper-lobe adenocarcinoma | Yes | Yes | Sensitive |